| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882869 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 7 Pages |
Abstract
These findings suggest that both NGAL and CysC are very sensitive markers that reflect renal impairment in newly diagnosed patients with MM. The high levels of NGAL in asymptomatic patients and in MGUS patients support the hypothesis of the presence of renal damage in these patients early in the course of their disease and may reveal NGAL to be an early marker that predicts the presence of renal impairment in MM.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, Dimitrios Christoulas, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Alexandra Margeli, Ioannis Papassotiriou, Meletios A. Dimopoulos,